glp 1 agonist saxenda Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States Saxenda for Weight Loss: Uses,
Pay in 4 interest-free payments of $6.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Saxenda for Weight Loss: Uses,](https://images.ctfassets.net/1clcztbbevpp/32JWkEPaMfea2iBEyYZp3W/dd812edf3ff0e6abb685af17cfa3c1f2/injectable-weight-loss.jpg?w=1200&q=60)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Saxenda for Weight Loss: Uses,](https://secure.proactrx.com/media/filer_public/f6/6f/f66fd578-4e9f-4c30-a83d-88de87432593/saxenda_approval.jpg)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Saxenda for Weight Loss: Uses,](https://insulinoutlet.com/wp-content/uploads/2021/08/Saxenda-Pen.png)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Saxenda for Weight Loss: Uses,](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2025/08/shutterstock_2365011949-430x241.jpg)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Saxenda for Weight Loss: Uses,](https://cdn.prod.website-files.com/6928b5f7f02708613ab9204f/6a4b3e89d191314fed58b7c1_saxenda%20hero%20img%20(1).webp)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States Saxenda for Weight Loss: Uses,](https://i.ytimg.com/vi/rU-vSk7Y_SM/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLCtEE7nvhFR84MWLxMLHfBQqvXXSg)
















